‹ Back to DRREDDY.NS

DRREDDY.NS Profit & Loss

Dr. Reddy's Laboratories Ltd.

Profit & Loss Balance Sheet Cash Flow

Profit & Loss · 9 years on file (FY2017-18 to FY2025-26) · fetched 2026-08-23 21:45
Line item FY2017-18 FY2018-19 FY2019-20 FY2020-21 FY2021-22 FY2022-23 FY2023-24 FY2024-25 FY2025-26 Source (XBRL element)
Revenue from Operations ₹142.81 Bn ₹154.48 Bn ₹175.17 Bn ₹190.47 Bn ₹215.45 Bn ₹246.70 Bn ₹280.11 Bn ₹326.44 Bn ₹337.00 Bn RevenueFromOperations
Gross Revenue (incl. inter-segment) ₹142.81 Bn ₹154.48 Bn ₹175.17 Bn ₹190.47 Bn ₹215.45 Bn ₹246.70 Bn ₹280.11 Bn ₹326.44 Bn ₹337.00 Bn SegmentRevenueFromOperations
Other Income ₹1.55 Bn ₹3.38 Bn ₹6.21 Bn ₹2.91 Bn ₹4.84 Bn ₹10.55 Bn ₹8.94 Bn ₹10.97 Bn ₹13.58 Bn OtherIncome
Total Income ₹144.36 Bn ₹157.86 Bn ₹181.38 Bn ₹193.39 Bn ₹220.30 Bn ₹257.25 Bn ₹289.05 Bn ₹337.41 Bn ₹350.59 Bn Income
Cost of Materials Consumed ₹26.31 Bn ₹28.89 Bn ₹29.85 Bn ₹42.96 Bn ₹43.12 Bn ₹42.20 Bn ₹44.90 Bn ₹56.84 Bn ₹65.01 Bn CostOfMaterialsConsumed
Purchases of Stock-in-Trade ₹14.50 Bn ₹18.81 Bn ₹25.46 Bn ₹25.74 Bn ₹34.84 Bn ₹33.67 Bn ₹43.99 Bn ₹48.41 Bn ₹61.62 Bn PurchasesOfStockInTrade
Changes in Inventories ₹-0.41 Bn ₹-2.75 Bn ₹0.24 Bn ₹-7.91 Bn ₹-3.54 Bn ₹0.71 Bn ₹-6.80 Bn ₹-5.45 Bn ₹-4.24 Bn ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense ₹32.15 Bn ₹33.56 Bn ₹33.80 Bn ₹36.30 Bn ₹38.86 Bn ₹46.47 Bn ₹50.30 Bn ₹55.80 Bn ₹59.91 Bn EmployeeBenefitExpense
Finance Costs ₹0.79 Bn ₹0.89 Bn ₹0.98 Bn ₹0.97 Bn ₹0.96 Bn ₹1.43 Bn ₹1.71 Bn ₹2.83 Bn ₹3.74 Bn FinanceCosts
Depreciation and Amortisation ₹10.77 Bn ₹11.35 Bn ₹11.63 Bn ₹12.29 Bn ₹11.65 Bn ₹12.50 Bn ₹14.70 Bn ₹17.04 Bn ₹20.59 Bn DepreciationDepletionAndAmortisationExpense
Other Expenses ₹46.75 Bn ₹44.19 Bn ₹61.12 Bn ₹54.69 Bn ₹64.50 Bn ₹60.16 Bn ₹68.39 Bn ₹85.37 Bn ₹90.17 Bn OtherExpenses
Total Expenses ₹130.86 Bn ₹134.94 Bn ₹163.08 Bn ₹165.03 Bn ₹190.38 Bn ₹197.14 Bn ₹217.19 Bn ₹260.83 Bn ₹296.79 Bn Expenses
Profit Before Exceptional Items and Tax ₹13.50 Bn ₹22.92 Bn ₹18.30 Bn ₹28.36 Bn ₹29.91 Bn ₹60.12 Bn ₹71.86 Bn ₹76.58 Bn ₹53.79 Bn ProfitBeforeExceptionalItemsAndTax
Exceptional Items ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ExceptionalItemsBeforeTax
Profit Before Tax ₹13.50 Bn ₹22.92 Bn ₹18.30 Bn ₹28.36 Bn ₹29.91 Bn ₹60.12 Bn ₹71.86 Bn ₹76.58 Bn ₹53.79 Bn ProfitBeforeTax
Tax Expense ₹4.38 Bn ₹3.86 Bn ₹-1.40 Bn ₹9.32 Bn ₹8.79 Bn ₹15.41 Bn ₹16.23 Bn ₹19.54 Bn ₹12.35 Bn TaxExpense
Net Profit (incl. minority interest) ₹9.47 Bn ₹19.50 Bn ₹20.26 Bn ₹19.52 Bn ₹21.82 Bn ₹45.07 Bn ₹55.78 Bn ₹57.25 Bn ₹41.58 Bn ProfitLossForPeriod
Net Profit (to shareholders) ₹9.47 Bn ₹19.50 Bn ₹20.26 Bn N/A N/A N/A ₹0.00 Bn ₹56.55 Bn ₹41.96 Bn ProfitOrLossAttributableToOwnersOfParent
Basic EPS ₹57.08 ₹117.53 ₹122.22 ₹117.67 ₹131.57 ₹271.47 ₹335.22 ₹67.89 ₹50.41 BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS ₹56.96 ₹117.33 ₹121.99 ₹117.34 ₹131.21 ₹270.90 ₹334.59 ₹67.79 ₹50.35 DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from DRREDDY.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).